A detailed history of Counterpoint Mutual Funds LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Counterpoint Mutual Funds LLC holds 1,099 shares of LLY stock, worth $829,745. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,099
Holding current value
$829,745
% of portfolio
0.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $848,581 - $1.06 Million
1,099 New
1,099 $973,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Counterpoint Mutual Funds LLC Portfolio

Follow Counterpoint Mutual Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Counterpoint Mutual Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Counterpoint Mutual Funds LLC with notifications on news.